Somatic Features of Response and Relapse in Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy-Reference-Cited by-同舟云学术

Somatic Features of Response and Relapse in Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy

Published:2021-12 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Bacon Jack V.W.,Müller David C.,Ritch Elie,Annala Matti,Dugas Sarah G.,Herberts Cameron,Vandekerkhove Gillian,Seifert Helge,Zellweger Tobias,Black Peter C.,Bubendorf Lukas,Wyatt Alexander W.,Rentsch Cyrill A.

Funder

Canadian Institutes of Health Research

Krebsliga Schweiz

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference37 articles.

1. Predicting response to intravesical bacillus Calmette-Guérin immunotherapy: are we there yet? A systematic review;Kamat;Eur Urol,2018

2. Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder;Xylinas;Br J Cancer,2013

3. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer;Lindskrog;Nat Commun,2021

4. Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets;Pietzak;Eur Urol,2017

5. Genomic predictors of good outcome, recurrence, or progression in high-grade T1 non-muscle-invasive bladder cancer;Bellmunt;Cancer Res,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biomarkers of progression in non-muscle-invasive bladder cancer — beyond conventional risk stratification;Nature Reviews Urology;2024-08-02

2. Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review;Pharmacological Research;2024-08

3. Attenuated mutants of Salmonella enterica Typhimurium mediate melanoma regression via an immune response;Experimental Biology and Medicine;2024-06-21

4. Optimizing outcomes for high-risk, non-muscle-invasive bladder cancer: The evolving role of PD-(L)1 inhibition;Urologic Oncology: Seminars and Original Investigations;2023-12

5. Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence;Diagnostics;2023-10-13